This article is more than 5 years old. Information may no longer be current.

OTE200: VTE prophylaxis in orthopaedic patients

Issue: March 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

What should be the role of venous thromboembolism (VTE) chemoprophylaxis in patients at risk for VTE or with comorbidities who undergo orthopaedic surgery?

A note from the editors: The OTE200 is a group of approximately 200 European orthopaedic practitioners, educators and researchers whose opinions we poll each month. If you would like to be considered for membership, please send a request to orthopedics@healio.com.